Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study

Gut

Volumn 54, Issue 4, 2005, Pages 533-539

  Davila, J A ^b   Morgan, R O ^b   Shaib, Y ^b   McGlynn, K A ^c   El Serag, H B ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NCI/DHHS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALCOHOL LIVER DISEASE; ARTICLE; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMOCHROMATOSIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; UNITED STATES;

AGED; CARCINOMA, HEPATOCELLULAR; DIABETES COMPLICATIONS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; METABOLIC SYNDROME X; SEER PROGRAM; UNITED STATES;

EID: 15544382574     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.052167     Document Type: Article

References (25)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
2. El-Serag HB, Davila J, Petersen N, et al. The continuing rise in hepatocellular carcinoma in the United States: An Update. Ann Intern Med, 2003;18, 139:817-23.
3. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000;160:3227-30.
4. Hassan MM, Frame A, Patt YZ, et al. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 2002;35:266-9.
5. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-44.
6. Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-9.
7. Powell EE, Cooksley WGE, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1989;11:74-80.
8. Lee RG. Nonalcoholic steatohepatitis: A study of 49 patients. Hum Pathol 1989;20:594-8.
9. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
10. Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62.
11. Petrides AS, Vogt C, Schulze-Berge D, et al. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994;19:616-27.
12. El-Serag HB, Tran T, Everhart J. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma: a cohort study among US veterans. Gastroenterology 2003;126:460-8.
13. Wideroff L, Gridley G, Mellemkiaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360-5.
14. Adami HO, McLaughlin J, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307-14.
15. Adami HO, Chow WH, Nyren O, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996;88:1472-7.
16. Fugino Y, Mizoue T, Tokui N, et al. Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes Metab Res Rev 2001;17:374-9.
17. Yu MC, Tong MJ, Govindarajan S, et al. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
18. Hassan MM, Hwang LY, Hatten CJ, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206-13.
19. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40(8 Suppl):IV-3-18.
20. The SEER Program Code Manual, 3rd ed. Bethesda: National Cancer Institute, 1998.
21. International Classification of Diseases, Ninth Revision. In: Clinical Modification, 4th edn., Washington, DC: Public Health Service, US Dept of Health and Human Services 1991.
22. Fleiss JL, Levin B, Poik MC. Statistical methods for rates and proportions, 3rd edn., Hoboken: John Wiley and Sons, Inc. 2003:250-4.
23. Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, Inc, 1989:106-18.
24. Kulkerni K, Barcak E, El-Serag HB, et al. Increasing incidence of hepatocellular carcinoma among US born residents of Houston, TX. Am J Gastroenterol 2003;98:S84.
25. Perseghin G, Mazzaferro V, Sereni LP, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology 2000;31:694-703.